Skip to search formSkip to main contentSkip to account menu

Constipation

Known as: UMMETUS, Costiveness, constipating 
Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or… 
National Institutes of Health

Related topics

Related topics

47 relations
Aloe ExtractAnaplastic Carcinoma of the RectumAutonomic nervous system disordersCastor Oil

Narrower (1)

Dyschezia

Broader (1)

Intestinal Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial.
Highly Cited
2013
Highly Cited
2013
Regulatory T cells: recommendations to simplify the nomenclature
c o rr e s p o n d e n c e npg © 2013 Nature America, Inc. All rights reserved. Regulatory T cells: recommendations to simplify… 
Review
2004
Review
2004
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
Highly Cited
2002
Highly Cited
2002
Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation
Background: Interstitial cells of Cajal (ICC) are required for normal intestinal motility. ICC are found throughout the human… 
Highly Cited
2001
Highly Cited
2001
Tegaserod, a 5‐HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation
To investigate the efficacy and safety of tegaserod, a novel 5‐HT4 receptor partial agonist, in a randomized, double‐blind… 
Review
2001
Review
2001
Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology
Highly Cited
2001
Highly Cited
2001
Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder.
BACKGROUND & AIMS Prucalopride (PRU) is a selective benzofuran 5-hydroxytryptamine(4)-receptor agonist with gastrointestinal and… 
Highly Cited
2000
Highly Cited
2000
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
Review
2000
Review
2000
Physical health consequences of physical and psychological intimate partner violence.
BACKGROUND Past studies that have addressed the health effects of intimate partner violence (IPV) have defined IPV as violence… 
Highly Cited
1998
Highly Cited
1998
The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)